The role of [18F]fluoride positron emission tomography in the early detection of aseptic loosening of total knee arthroplasty

International Journal of Surgery

Volumn 5, Issue 2, 2007, Pages 99-104

  Sterner, T ^a   Pink, R ^a   Freudenberg, L ^a   Jentzen, T ^a   Quitmann, H ^a   Bockisch, A ^a   Loer F ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Aseptic loosening; F PET; Prosthesis; Total knee arthroplasty

Indexed keywords

FLUORINE 18; DIAGNOSTIC AGENT; FLUORINE; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; BONE METABOLISM; CLINICAL ARTICLE; COMPARATIVE STUDY; EARLY DIAGNOSIS; FEMALE; FOLLOW UP; HUMAN; MALE; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSTHESIS LOOSENING; RADIOGRAPHY; SENSITIVITY AND SPECIFICITY; TOTAL KNEE REPLACEMENT; CLINICAL TRIAL; KNEE ARTHROPLASTY; KNEE PROSTHESIS; MIDDLE AGED; PREDICTION AND FORECASTING; PROSPECTIVE STUDY; PROSTHESIS FAILURE; REOPERATION;

AGED; AGED, 80 AND OVER; ARTHROPLASTY, REPLACEMENT, KNEE; EARLY DIAGNOSIS; FEMALE; FLUORINE RADIOISOTOPES; FOLLOW-UP STUDIES; HUMANS; KNEE PROSTHESIS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PROSTHESIS FAILURE; RADIOPHARMACEUTICALS; REOPERATION;

EID: 34247164144     PISSN: 17439191     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijsu.2006.05.002     Document Type: Article

References (19)

1. Algan S.M., Purdon M., and Horowitz S.M. Role of tumor necrosis factor alpha in particulate-induced bone resorption. J Orthop Res 14 (1996) 30-35
2. Ingham E., Green T.R., Matthews J.B., Stone M.H., and Fisher J. Influence of TNF-alpha in polyethylene particle stimulated macrophage bone resorption. 45th Annual Meeting (1999), Orthopaedic Research Society, Anaheim, California
3. Merkel K.D., Erdmann J.M., McHugh K.P., Abu-Amer Y., Ross F.P., and Teitelbaum S.L. Tumor necrosis factor alpha mediates orthopaedics implant osteolysis. Am J Pathol 154 (1999) 203-210
4. Sterner T., Schütze N., Saxler G., Jakob F., and Rader C.P. Effects of clinically relevant alumina ceramic particles, zirconia ceramic particles and titanium particles of different sizes and concentrations on TNF alpha release in a human moncytic cell line. Biomed Tech 49 12 (2004) 340-344
5. Levitsky K.A., Hozack W.J., Balderston R.A., Rothman R.H., Gluckman S.J., Maslack M.M., et al. Evaluation of the painful prosthetic joint. Relative value of bone scan, sedimentation rate and joint aspiration. J Arthroplasty 6 (1991) 237-244
6. Palestro C.J., and Torres M.A. Radionuclide imaging in orthopedic infections. Semin Nucl Med 27 4 (1997) 334-345
7. 18F]fluoride ion in renal osteodystrophy: correlation with bone histomorphometry. J Clin Endocrinol Metab 77 4 (1993) 949-955
8. Hawkins R.A., Choi Y., Huang S.C., Hoh C.K., Dahlbom M., Schiepers C., et al. Evaluation of the skeletal kinetics of fluorine-18-fluoride ion with PET. J Nucl Med 33 5 (1992) 633-642
9. 18F]fluoride ion positron emission tomography. Eur J Nucl Med 26 6 (1999) 615-624
10. 18F]fluorodeoxyglucose positron emission tomography to differentiate between synovitis, loosening and infection of the hip and knee prosthesis. Nucl Med Commun 23 (2002) 645-653
11. Bengston S., and Knutson K. The infected knee arthroplasty. A 6-year follow-up of 357 cases. Acta Orthop Scand 62 (1991) 301-311
12. Haynes D.R., Crotti T.N., and Potter A.E. The osteoclastogenic molecules RANKL and RANK are associated with periprosthetic osteolysis. J Bone Joint Surg 83-B (2001) 902-911
13. Mandelin J., Li T.-F., Liljeström M., Kroon M.E., Hanemaaijer R., Santavirta S., et al. Imbalance of RANKL/RANK/OPG system in interface tissue in loosening of total hip replacement. J Bone Joint Surg 85-B 8 (2003) 1196-1201
14. 18F]fluoride PET indicates reduced bone formation in severe glucocorticoid-induced osteoporosis. Nuklearmedizin 37 2 (1998) 76-79
15. Schiepers C., Broos P., Miserez M., Bormans G., and De Roo M. Measurement of skeletal flow with positron emission tomography and 18F-fluoride in femoral head osteonecrosis. Arch Orthop Trauma Surg 118 3 (1998) 131-135
16. Cook G.J., and Fogleman I. The role of positron emission tomography in skeletal disease. Semin Nucl Med 31 1 (2001) 50-61
17. Even-Sapir E., Metser U., Flusser G., Zuriel L., Kollender Y., Lerman H., et al. Assessment of malignant skeletal disease: initial experience with 18F-fluoride PET/CT and comparison between 18F-fluoride PET and 18F-fluoride PET/CT. J Nucl Med 45 2 (2004) 272-278
18. Zhuang H., Duarte P.S., Pourdehnad M., Shnier D., and Alavi A. Exclusion of chronic osteomyelitis with F-18 fluorodeoxyglucose positron tomographic imaging. Clin Nucl Med 25 (2000) 281-284
19. Goerres G.W., Ziegler S.I., Burger C., Berthold T., Von Schulthess G.K., and Buck A. Artifacts at PET and PET/CT caused by metallic hip prosthetic material. Radiology 226 2 (2003) 577-584